Related Experiment Video
Updated: Jun 11, 2026

08:34
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
A VMAT planning solution for prostate patients using a commercial treatment planning system
C J Boylan1, C Golby, C G Rowbottom
1North Western Medical Physics, The Christie NHS Foundation Trust, Wilmslow Road, Manchester M20 4BX, UK. hristopher.Boylan@physics.cr.man.ac.uk
Physics in Medicine and Biology
|July 6, 2010
Summary
Volumetric modulated arc therapy (VMAT) planning for prostate cancer offers comparable target coverage to intensity-modulated radiation therapy (IMRT) while improving critical structure sparing and reducing treatment time. This in-house solution demonstrates robust and repeatable VMAT plan delivery.
Area of Science:
- Radiation Oncology
- Medical Physics
Background:
- Volumetric modulated arc therapy (VMAT) is an advanced radiation delivery technique offering potential advantages over traditional fixed-beam intensity-modulated radiation therapy (IMRT).
- Commercial VMAT planning systems exist, but in-house solutions allow for greater control and detailed investigation of planning processes.
Purpose of the Study:
- To describe the development and validation of an in-house single-arc VMAT planning method for prostate cancer using an existing treatment planning system.
- To compare the dosimetric and delivery characteristics of the developed VMAT technique against a standard IMRT approach.
Main Methods:
- Utilized Philips Pinnacle(3) v.8.0 TPS supplemented by in-house software for VMAT plan generation.
- Initiated planning with static IMRT segments, modified them, and sequenced into a single 360-degree arc with 60 control points.
- Conducted dose-volume histogram analysis and dosimetric verification, resilience, and repeatability tests.
Main Results:
- VMAT plans achieved dose-level target coverage comparable to standard IMRT.
- VMAT demonstrated superior sparing of critical organs at risk, specifically the rectum and bladder.
- Treatment delivery times were significantly reduced using the VMAT method.
Conclusions:
- The developed in-house VMAT planning solution provides a robust and effective alternative for prostate cancer treatment.
- This method achieves comparable target coverage to IMRT while enhancing organ-at-risk sparing and treatment efficiency.
- The approach is validated through dosimetric verification, showing resilience and repeatability.

